Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 999,500 | 536,900 | 539,600 | 432,400 | 479,200 |
| Marketable Securities | 84,600 | 209,800 | 447,500 | 295,900 | 303,200 |
| Receivables | 1,520,500 | 1,550,200 | 950,100 | 898,600 | 834,700 |
| Inventories | 839,600 | 968,900 | 1,103,000 | 938,400 | 796,900 |
| Other current assets | 694,400 | 696,500 | 656,900 | 440,700 | 525,300 |
| TOTAL | $4,138,600 | $3,962,300 | $3,697,100 | $3,006,000 | $2,939,300 |
| Non-Current Assets | |||||
| PPE Net | 4,239,300 | 4,411,500 | 4,200,200 | 4,072,100 | 3,782,500 |
| Investments And Advances | 573,800 | 464,100 | 221,700 | 242,500 | 276,200 |
| Other Non-Current Assets | 5,460,800 | 5,669,500 | 1,504,600 | 1,352,200 | 1,300,600 |
| TOTAL | $10,273,900 | $10,545,100 | $5,926,500 | $5,666,800 | $5,359,300 |
| Total Assets | $14,412,500 | $14,507,400 | $9,623,600 | $8,672,800 | $8,298,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,018,000 | 878,200 | 329,600 | 323,600 | 276,300 |
| Accrued Expenses | 316,000 | 304,600 | 328,600 | 272,800 | 295,100 |
| Other current liabilities | 1,063,700 | 1,253,900 | 1,299,000 | 751,200 | 571,300 |
| TOTAL | $4,967,000 | $5,669,500 | $2,928,000 | $2,398,600 | $2,272,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,592,900 | 2,125,800 | 835,200 | 582,300 | 395,500 |
| Other Non-Current Liabilities | 1,124,500 | 1,167,600 | 1,164,100 | 630,100 | 249,400 |
| TOTAL | $4,012,900 | $3,482,300 | $2,126,800 | $1,382,100 | $1,060,500 |
| Total Liabilities | $8,979,900 | $9,151,800 | $5,054,800 | $3,780,700 | $3,332,500 |
| Shareholders' Equity | |||||
| Common Shares | 355,600 | 183,000 | 183,000 | 183,000 | 183,000 |
| Retained earnings | 6,484,300 | 5,062,100 | 4,500,900 | 4,743,100 | 4,693,000 |
| Other shareholders' equity | -199,600 | -256,200 | -406,700 | -333,900 | -235,000 |
| TOTAL | $5,432,600 | $5,355,600 | $4,568,800 | $4,892,100 | $4,966,100 |
| Total Liabilities And Equity | $14,412,500 | $14,507,400 | $9,623,600 | $8,672,800 | $8,298,600 |